Vaccine development during global epidemics: the Zika experience

PMS Castanha, ETA Marques - The Lancet Infectious Diseases, 2020 - thelancet.com
The North and South American continents experienced a major epidemic of Zika virus in
2015–16, which infected up to 70% of the population in some areas. 1 Until then, Zika virus …
被引用次数：10 相关文章

[引用][C] Vaccine development during global epidemics: the Zika experience

PMS Castanha, ETA Marques - The Lancet. Infectious …, 2020 - pubmed.ncbi.nlm.nih.gov
Vaccine development during global epidemics: the Zika experience Vaccine development
during global epidemics: the Zika experience Lancet Infect Dis. 2020 Sep;20(9):998-999. doi …

Vaccine development during global epidemics: the Zika experience.

PMS Castanha, ETA Marques - The Lancet. Infectious Diseases, 2020 - europepmc.org
The North and South American continents experienced a major epidemic of Zika virus in
2015–16, which infected up to 70% of the population in some areas. 1 Until then, Zika virus …
[HTML] nih.gov

[HTML][HTML] Vaccine development during global epidemics: the Zika experience

PMS Castanha, ETA Marques - The Lancet. Infectious Diseases, 2020 - ncbi.nlm.nih.gov
The North and South American continents experienced a major epidemic of Zika virus in
2015–16, which infected up to 70% of the population in some areas. 1 Until then, Zika virus …

Vaccine development during global epidemics: the Zika experience.

PMS Castanha, ETA Marques - The Lancet. Infectious Diseases, 2020 - europepmc.org
This is a comment on" Safety and immunogenicity of a Zika purified inactivated virus vaccine
given via standard, accelerated, or shortened schedules: a single-centre, double-blind …